Preemptive diagnosis and treatment of Epstein-Barr virus-associated post transplant lymphoproliferative disorder after hematopoietic stem cell transplant: an approach in development.
about
Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelinesWhat is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients?Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes.Epstein-barr virus related lymphoproliferations after stem cell transplantation.Epstein-Barr virus replication linked to B cell proliferation in inflamed areas of colonic mucosa of patients with inflammatory bowel diseaseQuantitative real-time polymerase chain reaction for evaluating DNAemia due to cytomegalovirus, Epstein-Barr virus, and BK virus in solid-organ transplant recipients.Kinetics of Epstein-Barr virus DNA load in different blood compartments of pediatric recipients of T-cell-depleted HLA-haploidentical stem cell transplantation.Quantitative Epstein-Barr virus shedding and its correlation with the risk of post-transplant lymphoproliferative disorder.Rituximab in hematopoietic cell transplantation.Epstein-Barr virus-related lymphoproliferative disorder induced by equine anti-thymocyte globulin therapy.Immunotherapeutic options for Epstein-Barr virus-associated lymphoproliferative disease following transplantation.Secondary cancers following allogeneic haematopoietic cell transplantation in adults.Graft-vs-host disease following allogeneic hematopoietic cell transplantation.Molecular diagnosis and management of viral infections in hematopoietic stem cell transplant recipients.Immunosuppression-related lymphomas and cancers in IBD: how can they be prevented?EBV-induced post transplant lymphoproliferative disorders: a persisting challenge in allogeneic hematopoetic SCT.Opportunistic infections due to inflammatory bowel disease therapy.Epstein-Barr virus serology and PCR: conflicting results in an immunocompetent host. A case report and review of literature.The Epstein-Barr virus DNA load in the peripheral blood of transplant recipients does not accurately reflect the burden of infected cells.Investigation on the association between thyroid tumorigeneses and herpesviruses.Epstein-Barr virus: general factors, virus-related diseases and measurement of viral load after transplant.Epstein-Barr virus and posttransplant lymphoproliferative disorder in solid organ transplantation.Circulating cell-free and Epstein-Barr virus DNA in pediatric B-non-Hodgkin lymphomas.Reduced PTLD-related mortality in patients experiencing EBV infection following allo-SCT after the introduction of a protocol incorporating pre-emptive rituximab.Epstein-Barr virus reactivation in allogeneic stem cell transplantation is highly related to cytomegalovirus reactivation.Molecular diagnosis of Epstein-Barr virus infections.Prognostic factors and outcome of Epstein-Barr virus DNAemia in high-risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab.Monitoring of Epstein-Barr virus load in patients after allogeneic hematopoietic stem cell transplantation.Cellular normalization of viral DNA loads on whole blood improves the clinical management of cytomegalovirus or Epstein Barr virus infections in the setting of pre-emptive therapy.ATG prevents severe acute graft-versus-host disease in mismatched unrelated donor hematopoietic cell transplantation.Discrepancy in EBV-DNA load between peripheral blood and cerebrospinal fluid in a patient with isolated CNS post-transplant lymphoproliferative disorder.Immunomagnetic isolation of CD4+CD25+FoxP3+ natural T regulatory lymphocytes for clinical applications.Adoptive cell therapy against EBV-related malignancies: a survey of clinical results
P2860
Q26745838-12458EEC-A884-4C09-B92A-93D8CA909D4AQ27687191-839A1364-FD3A-45FB-A9B4-1DB2937AF53EQ34450754-5812D04C-92E4-4496-B48A-DA60891EC271Q34549457-01D1D342-CAF0-43B0-8C5E-B4E83DE10693Q34644510-A3AC0B9A-2C58-40F7-9B73-2CA4F54EF131Q36945756-3E9D0038-142D-4C34-8043-C61EBD8A57FCQ36957919-62060C14-0380-4B8B-896D-9A74BDFB0430Q37031384-63C014BC-A456-4E0E-BEE4-6214AFE0C618Q37737311-9CA8CFB5-246B-4BCB-AC3A-2C85122E74DDQ37777360-A757912C-9107-4631-98E9-BE486E49FD1DQ37793222-16A9E263-5471-4BC4-8907-2430300D3C7CQ37880254-E5E917FC-747E-4526-BB2A-E3B6A94D2B91Q37942818-81AF46F7-EB00-47D6-8AFA-A1E002F012E4Q38002109-8DBDD0F2-4F5C-477E-9905-9EAA9F72D3D1Q38026406-4A22D7A0-F812-4514-8C3B-941EB666FEF3Q38119843-97F781FF-3D5A-42B9-8DE1-C370A138EE9CQ38139812-44BC7FE0-3D6D-44B7-A89A-0F6DCDBE69F1Q38219320-FF14737F-E3E3-4E5A-A207-F14AE3B4AA89Q39311630-DFCCE47F-942F-47F3-8C50-02344B5FEC37Q40300872-18DE818D-E722-43D1-8A98-1F026FAB11E9Q42269563-7D39D5AF-7105-4B55-9D55-CED7453AA44FQ42272334-FFEF5DD9-5D64-49B3-BD36-6D072075D38EQ43063274-F2D2C339-3C1D-41F0-A091-D62A767C5D22Q44150295-296E7CEF-5544-4783-88BC-E69B0740FEBBQ45350676-172589CC-E7A0-41A6-8B63-B7E7B6076A39Q45352227-B9422D34-8B06-4A82-9CA4-6CB640AF2F1FQ45352633-1018F0AC-3C7A-4E1B-8C2A-9FCD64B8AC08Q45358118-653D76EC-0BF7-4C31-98BC-47A2EF1B7A22Q45388439-71815528-3FDF-44C3-A88F-66BBABB2FF0CQ47114028-1F645684-E4CC-4127-B903-257801EFF8AFQ48806049-7B76C27E-E5BB-49F2-A50A-2DD6AAB3FD3CQ51764965-FB711BC3-6956-4839-82F8-C507F733075BQ57056125-B8A89AC8-2376-45F3-97BF-589C626161FF
P2860
Preemptive diagnosis and treatment of Epstein-Barr virus-associated post transplant lymphoproliferative disorder after hematopoietic stem cell transplant: an approach in development.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Preemptive diagnosis and treat ...... t: an approach in development.
@ast
Preemptive diagnosis and treat ...... t: an approach in development.
@en
type
label
Preemptive diagnosis and treat ...... t: an approach in development.
@ast
Preemptive diagnosis and treat ...... t: an approach in development.
@en
prefLabel
Preemptive diagnosis and treat ...... t: an approach in development.
@ast
Preemptive diagnosis and treat ...... t: an approach in development.
@en
P2093
P2860
P356
P1476
Preemptive diagnosis and treat ...... t: an approach in development.
@en
P2093
Ambrossi GG
Jakubowski A
Weinstock DM
P2860
P2888
P304
P356
10.1038/SJ.BMT.1705289
P407
P577
2006-03-01T00:00:00Z
P5875
P6179
1029335424